Pfizer hikes US prices for over 100 drugs on January 1 - (CNBC via NewsPoints Desk)

  • Information compiled by Wolters Kluwer revealed that Pfizer implemented price increases for more than 100 drugs in the US earlier this month, some by as much as 20 percent, as reported CNBC Friday.
  • Pfizer acknowledged price increases of 9.4 percent for Lyrica, 12.9 percent for Viagra and 5 percent for Ibrance.
  • Meanwhile, UBS stated that Pfizer raised the prices for the anticonvulsant Dilantin, hormone therapy Menest, angina drug Nitrostat, irregular heartbeat treatment Tykosyn and antibiotic Tygacil by 20 percent each.
  • No price reductions were reported for the company.
  • Pfizer previously reached an agreement to merge with Allergan in an effort to reduce its tax liability.

To read more NewsPoints articles, click here.